Business · 16/12/2009
FDA Approves Supplemental New Animal Drug Application for Florfenicol Injectable Solution
The FDA is amending its regulations to reflect the approval of a supplemental new animal drug application (NADA) for Intervet, Inc.'s florfenicol injectable solution, which is now approved to treat bovine respiratory disease pathogens including Mycoplasma bovis.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →